Lipid formulations containing bioactive fatty acids and other bioactive agents
AssigneeSciadonics, Inc.
InventorAlvin Berger
Life of this patent
Estimating the term…
Abstract
Provided herein is technology relating to compositions containing bioactive non-methylene interrupted fatty acids (NMIFAs) in combination with short chain fatty acids, medium chain fatty acids, ketone bodies and/or endocannabinoids and endocannabinoid-related mediators, and particularly, but not exclusively, to compositions and methods related to the production and use of non-methylene interrupted fatty acids such as sciadonic acids, juniperonic acid, pinoleic acid and dihomopinoleic acid in combination with short chain fatty acids, medium chain fatty acids and/or endocannabinoids and endocannabinoid-related mediators.
Claims19
A formulation comprising at least 1% w/w non-methylene interrupted fatty acids (NMIFAs) and a second bioactive agent selected from the group consisting of at least 5% w/w medium chain fatty acids, at least 5% w/w short chain fatty acids, at least 1% w/w of endocannabinoids or endocannabinoid mediators, and combinations thereof.
Dependencies are inferred from the claim text.